Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and HPA Axis Reactivity in Mothers
NCT03593473Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2019
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in postpartum depression (PPD), anxiety disorder, psychological stress, sponsored by University of North Carolina at Chapel Hill. Started Feb 2019; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
postpartum depression (PPD)anxiety disorderpsychological stress
Beyond the preview
Go deeper on NCT03593473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593473.